Clinical trial
Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer
NCT03457779
Study timeline
Study start (actual)2018-02-08Date precision: day
Registry last updated2021-10-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Triple Negative Breast Cancerunresolved
Interventions
GlucoseDIETARY_SUPPLEMENT
Sponsors & collaborators
Baylor Research Institutelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03457779 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.